These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25210842)

  • 1. Cell therapy with embryonic stem cell-derived cardiomyocytes encapsulated in injectable nanomatrix gel enhances cell engraftment and promotes cardiac repair.
    Ban K; Park HJ; Kim S; Andukuri A; Cho KW; Hwang JW; Cha HJ; Kim SY; Kim WS; Jun HW; Yoon YS
    ACS Nano; 2014 Oct; 8(10):10815-25. PubMed ID: 25210842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Therapeutic and Long-Term Dynamic Vascularization Effects of Human Pluripotent Stem Cell-Derived Endothelial Cells Encapsulated in a Nanomatrix Gel.
    Lee SJ; Sohn YD; Andukuri A; Kim S; Byun J; Han JW; Park IH; Jun HW; Yoon YS
    Circulation; 2017 Nov; 136(20):1939-1954. PubMed ID: 28972000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
    Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction.
    Park SJ; Kim RY; Park BW; Lee S; Choi SW; Park JH; Choi JJ; Kim SW; Jang J; Cho DW; Chung HM; Moon SH; Ban K; Park HJ
    Nat Commun; 2019 Jul; 10(1):3123. PubMed ID: 31311935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction.
    Moon SH; Kang SW; Park SJ; Bae D; Kim SJ; Lee HA; Kim KS; Hong KS; Kim JS; Do JT; Byun KH; Chung HM
    Biomaterials; 2013 May; 34(16):4013-4026. PubMed ID: 23465823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes.
    Funakoshi S; Miki K; Takaki T; Okubo C; Hatani T; Chonabayashi K; Nishikawa M; Takei I; Oishi A; Narita M; Hoshijima M; Kimura T; Yamanaka S; Yoshida Y
    Sci Rep; 2016 Jan; 6():19111. PubMed ID: 26743035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial repair of bioengineered cardiac patches with decellularized placental scaffold and human-induced pluripotent stem cells in a rat model of myocardial infarction.
    Jiang Y; Sun SJ; Zhen Z; Wei R; Zhang N; Liao SY; Tse HF
    Stem Cell Res Ther; 2021 Jan; 12(1):13. PubMed ID: 33413626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
    Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model.
    Thompson SA; Burridge PW; Lipke EA; Shamblott M; Zambidis ET; Tung L
    J Mol Cell Cardiol; 2012 Jul; 53(1):15-23. PubMed ID: 22713758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo.
    Luo J; Weaver MS; Cao B; Dennis JE; Van Biber B; Laflamme MA; Allen MD
    Stem Cells Transl Med; 2014 Jun; 3(6):734-44. PubMed ID: 24736402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The infarcted cardiac microenvironment cannot selectively promote embryonic stem cell differentiation into cardiomyocytes.
    Chen YR; Li Y; Chen L; Yang XC; Su PX; Cai J
    Cardiovasc Pathol; 2011; 20(2):77-83. PubMed ID: 20117024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and Electrical Integration of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart.
    Higuchi T; Miyagawa S; Pearson JT; Fukushima S; Saito A; Tsuchimochi H; Sonobe T; Fujii Y; Yagi N; Astolfo A; Shirai M; Sawa Y
    Cell Transplant; 2015; 24(12):2479-89. PubMed ID: 25606821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term improvement in postinfarct left ventricular global and regional contractile function is mediated by embryonic stem cell-derived cardiomyocytes.
    Qiao H; Zhang H; Yamanaka S; Patel VV; Petrenko NB; Huang B; Muenz LR; Ferrari VA; Boheler KR; Zhou R
    Circ Cardiovasc Imaging; 2011 Jan; 4(1):33-41. PubMed ID: 21059858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts.
    Dai W; Field LJ; Rubart M; Reuter S; Hale SL; Zweigerdt R; Graichen RE; Kay GL; Jyrala AJ; Colman A; Davidson BP; Pera M; Kloner RA
    J Mol Cell Cardiol; 2007 Oct; 43(4):504-16. PubMed ID: 17707399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
    Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of MG53 Enhances Cell Survival and Engraftment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Injured Hearts.
    Park KH; He X; Jiang L; Zhu H; Liang J; Wang Y; Ma J
    Stem Cell Rev Rep; 2023 Oct; 19(7):2420-2428. PubMed ID: 37477774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
    Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronate supports hESC-cardiomyocyte cell therapy for cardiac regeneration after acute myocardial infarction.
    Tan Y; Wang L; Chen G; Liu W; Li Z; Wang Y; Wang L; Li W; Wu J; Hao J
    Cell Prolif; 2020 Dec; 53(12):e12942. PubMed ID: 33107673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.